Skip to main content

ADAR1 Capital Management, LLC

13F filer · CIK 0001940272
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$2.19BU.S. long equity reported on 13F
Positions25638 new · 69 closed
Net flow last quarter+$161MBuys minus sells
Top 10 positions weight40.5%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 2026256 positions
ABVXAbivax S.A.$240M11.01%2.30%+29.5%Q1 2024
PTGXProtagonist Therapeutics, Inc$118M5.39%1.49%-3.4%Q4 2023
ROIVRoivant Sciences Ltd.$112M5.11%0.44%-3.9%Q4 2023
SPYSPDR S&P 500 ETF Trust$96.4M4.41%Not reported+70.0%Q2 2025
IMVTImmunovant, Inc.$89.8M4.11%1.13%-13.0%Q4 2023
ZLABZai Lab Ltd$64M2.93%0.30%+136.4%Q4 2023
AGIOAgios Pharmaceuticals, Inc.$47.8M2.19%2.16%+815.6%Q3 2024
CRNXCrinetics Pharmaceuticals, Inc.$45.7M2.09%1.16%+7.3%Q2 2024
CYTKCytokinetics Inc$39M1.79%0.37%-27.6%Q4 2023
SEPNSepterna, Inc.$31.5M1.44%2.06%-13.7%Q1 2025
AVRAnteris Technologies Global Corp.$31M1.42%3.23%-17.0%Q4 2024
EDITEditas Medicine, Inc.$28.8M1.32%9.08%NewQ2 2026
DNLIDenali Therapeutics Inc.$26.5M1.21%0.64%-45.0%Q1 2024
SYRESpyre Therapeutics, Inc.$25.2M1.15%0.32%-16.1%Q4 2023
VIRVir Biotechnology, Inc.$25M1.15%1.45%-10.5%Q2 2024
PRAXPraxis Precision Medicines, Inc.$24.9M1.14%0.27%+4850.2%Q4 2025
INSMINSMED Inc$24.4M1.12%0.10%+545.7%Q2 2024
CLDXCelldex Therapeutics, Inc.$23.1M1.05%0.79%+44.8%Q2 2024
VKTXViking Therapeutics, Inc.$22.4M1.02%0.49%+152.1%Q4 2023
TSHATaysha Gene Therapies, Inc.$20.7M0.95%0.93%+2.1%Q4 2023
MNPRMonopar Therapeutics$20.1M0.92%3.24%-17.7%Q4 2024
OVIDOvid Therapeutics Inc.$20M0.91%4.01%+63.2%Q4 2023
ELVNEnliven Therapeutics, Inc.$19.7M0.90%0.53%+17.7%Q4 2025
ENTAEnanta Pharmaceuticals Inc$19.6M0.90%4.62%+2518.0%Q4 2025
NKTRNektar Therapeutics$17M0.78%1.20%+51.4%Q3 2024
INSPInspire Medical Systems, Inc.$16.7M0.76%1.30%-7.6%Q3 2025
RVMDRevolution Medicines, Inc.$16.4M0.75%0.04%-34.6%Q4 2023
ESTAEstablishment Labs Holdings Inc.$15.9M0.73%0.62%-13.1%Q3 2024
PRTAProthena Corp Public Ltd Co$15.2M0.70%3.00%-1.7%Q4 2023
RYTMRhythm Pharmaceuticals, Inc.$15.1M0.69%0.20%-35.6%Q1 2024
IKTInhibikase Therapeutics, Inc.$15M0.69%5.60%+11.8%Q4 2024
QUREuniQure N.V.$15M0.68%0.47%+326.1%Q1 2024
RLYBRallybio Corp$14.8M0.68%17.46%+4411.1%Q1 2024
REGNRegeneron Pharmaceuticals, Inc.$13.8M0.63%0.02%+82.7%Q1 2024
IVAInventiva S.A.$13.6M0.62%1.87%+65.9%Q4 2025
STROSutro Biopharma, Inc.$13.4M0.61%2.44%-23.0%Q4 2025
IONSIonis Pharmaceuticals Inc$13.2M0.60%0.10%+3.7%Q1 2024
BBIOBridgeBio Pharma, Inc.$13.2M0.60%0.09%+87.4%Q4 2023
SRPTSarepta Therapeutics, Inc.$13.1M0.60%0.69%+178.8%Q4 2023
CTMXCytomX Therapeutics, Inc.$12.6M0.58%1.55%-1.3%Q1 2024
VORVor Biopharma Inc.$12.5M0.57%1.25%NewQ2 2026
EQEquillium, Inc.$12M0.55%5.93%+0.9%Q4 2023
ANLAdlai Nortye Ltd.$11.7M0.54%Not reported+763.2%Q1 2026
CLYMClimb Bio, Inc.$10.7M0.49%1.43%+37.6%Q2 2024
HLXCHelix Acquisition Corp. III$10.6M0.49%Not reportedNot reportedQ1 2026
ZURAZura Bio Ltd$10.4M0.48%1.84%+179.1%Q3 2024
OKUROnKure Therapeutics, Inc.$10.2M0.47%5.54%-8.1%Q1 2025
MAZEMaze Therapeutics, Inc.$10.1M0.46%0.61%+577.3%Q3 2025
XENEXenon Pharmaceuticals Inc.$10.1M0.46%0.17%-27.2%Q2 2024
TEVATeva Pharmaceutical Industries Ltd$9.41M0.43%0.02%+3.5%Q4 2023
Q1 2026Reported May 18, 2026287 positions
ABVXAbivax S.A.$155M9.14%1.78%+5.8%Q1 2024
PTGXProtagonist Therapeutics, Inc$105M6.17%1.55%-5.3%Q4 2023
ROIVRoivant Sciences Ltd.$91M5.36%0.46%-4.2%Q4 2023
IMVTImmunovant, Inc.$66.5M3.92%1.31%+8.0%Q4 2023
SPYSPDR S&P 500 ETF Trust$49.4M2.91%Not reported+38.9%Q2 2025
TERNTerns Pharmaceuticals, Inc.$48.2M2.84%0.79%+68.9%Q4 2023
CYTKCytokinetics Inc$41.7M2.45%0.51%+17.1%Q4 2023
CRNXCrinetics Pharmaceuticals, Inc.$41.4M2.44%1.08%+268.3%Q2 2024
DNLIDenali Therapeutics Inc.$35.9M2.12%1.18%+3490.9%Q1 2024
BEAMBeam Therapeutics Inc.$34.5M2.03%1.41%Not reportedQ2 2024
ZLABZai Lab Ltd$26.8M1.58%0.13%+14.4%Q4 2023
SEPNSepterna, Inc.$26.2M1.54%2.43%-5.9%Q1 2025
VIRVir Biotechnology, Inc.$24.6M1.45%1.70%Not reportedQ2 2024
DBVTDBV Technologies S.A.$21.2M1.25%0.34%NewQ1 2026
AVRAnteris Technologies Global Corp.$21M1.24%3.90%+205.9%Q4 2024
INSPInspire Medical Systems, Inc.$20.9M1.23%1.41%+2601.3%Q3 2025
SRRKScholar Rock Holding Corp$20M1.18%0.34%+485.3%Q2 2024
RYTMRhythm Pharmaceuticals, Inc.$18.4M1.08%0.31%+311.8%Q1 2024
SYRESpyre Therapeutics, Inc.$17.1M1.00%0.43%+893.6%Q4 2023
CTMXCytomX Therapeutics, Inc.$16M0.94%2.00%-18.5%Q1 2024
PRTAProthena Corp Public Ltd Co$15.4M0.90%2.98%+8.5%Q4 2023
SNYSanofi$15.3M0.90%0.03%+399.3%Q1 2024
PCVXVaxcyte, Inc.$15.1M0.89%0.18%-17.9%Q4 2023
MNPRMonopar Therapeutics$14.5M0.85%3.95%+13.0%Q4 2024
ABUSArbutus Biopharma Corp$14.1M0.83%1.59%-42.1%Q4 2023
AMLXAmylyx Pharmaceuticals, Inc.$13.9M0.82%0.90%+12.4%Q4 2023
CLDXCelldex Therapeutics, Inc.$13.6M0.80%0.64%-33.9%Q2 2024
TSHATaysha Gene Therapies, Inc.$13.3M0.78%1.04%+19.4%Q4 2023
XENEXenon Pharmaceuticals Inc.$13.3M0.78%0.24%+12.2%Q2 2024
STROSutro Biopharma, Inc.$13.1M0.77%3.17%+681.9%Q4 2025
RVMDRevolution Medicines, Inc.$13M0.77%0.07%-7.7%Q4 2023
ELVNEnliven Therapeutics, Inc.$12.9M0.76%0.54%+998.5%Q4 2025
CGONCG Oncology, Inc.$12.6M0.74%0.21%-28.1%Q1 2024
ESTAEstablishment Labs Holdings Inc.$12.1M0.71%0.73%+24.5%Q3 2024
REPLReplimune Group, Inc.$12.1M0.71%1.91%+27.5%Q2 2025
IVAInventiva S.A.$12.1M0.71%1.13%-19.8%Q4 2025
IONSIonis Pharmaceuticals Inc$12M0.71%0.10%+9.0%Q1 2024
NKTRNektar Therapeutics$11.6M0.68%0.79%+123.9%Q3 2024
IKTInhibikase Therapeutics, Inc.$11.1M0.65%5.00%-18.1%Q4 2024
SPRYARS Pharmaceuticals, Inc.$10.9M0.64%1.37%+268.4%Q3 2025
HLXCHelix Acquisition Corp. III$10.3M0.61%Not reportedNewQ1 2026
OVIDOvid Therapeutics Inc.$10.1M0.59%2.72%+6.1%Q4 2023
OKUROnKure Therapeutics, Inc.$10.1M0.59%17.81%+140.1%Q1 2025
REGNRegeneron Pharmaceuticals, Inc.$9.39M0.55%0.01%+0.9%Q1 2024
MLTXMoonLake Immunotherapeutics$8.52M0.50%0.87%Not reportedQ1 2024
LXEOLexeo Therapeutics, Inc.$8.42M0.50%1.98%+5.3%Q2 2024
IRDOpus Genetics, Inc.$8.41M0.50%2.59%+4522.5%Q4 2025
TEVATeva Pharmaceutical Industries Ltd$8.08M0.48%0.02%+13.7%Q4 2023
SVRASavara Inc$8M0.47%0.71%+4.2%Q1 2024
MPLTMapLight Therapeutics, Inc.$7.62M0.45%0.83%NewQ1 2026
Q4 2025Reported Feb 18, 2026244 positions
ABVXAbivax S.A.$178M13.05%1.68%-2.5%Q1 2024
PTGXProtagonist Therapeutics, Inc$91.6M6.73%1.68%+6.1%Q4 2023
ROIVRoivant Sciences Ltd.$74.4M5.46%0.48%+2.4%Q4 2023
IMVTImmunovant, Inc.$63.1M4.63%1.22%+10.7%Q4 2023
RNAMAvidity Biosciences, Inc.$39.4M2.90%0.36%+918.6%Q3 2024
SPYSPDR S&P 500 ETF Trust$37.3M2.74%Not reportedNot reportedQ2 2025
CYTKCytokinetics Inc$34.3M2.52%0.44%+4.1%Q4 2023
SEPNSepterna, Inc.$32.3M2.37%2.58%-1.6%Q1 2025
ABUSArbutus Biopharma Corp$26M1.91%2.81%+86.5%Q4 2023
ZLABZai Lab Ltd$22M1.61%0.11%+43.5%Q4 2023
TERNTerns Pharmaceuticals, Inc.$21.9M1.61%0.48%+5316.2%Q4 2023
CTMXCytomX Therapeutics, Inc.$17.8M1.31%2.46%+3.4%Q1 2024
CLDXCelldex Therapeutics, Inc.$17.6M1.29%0.97%+491.0%Q2 2024
RAPTRAPT Therapeutics, Inc.$17.3M1.27%1.84%+0.4%Q2 2024
IKTInhibikase Therapeutics, Inc.$16.5M1.21%6.12%+53.7%Q4 2024
BBIOBridgeBio Pharma, Inc.$16.3M1.20%0.11%-21.9%Q4 2023
MNPRMonopar Therapeutics$15.3M1.12%3.50%+79.9%Q4 2024
PCVXVaxcyte, Inc.$14.6M1.07%0.24%+48.1%Q4 2023
CRNXCrinetics Pharmaceuticals, Inc.$14.4M1.06%0.32%+24.6%Q2 2024
FULCFulcrum Therapeutics, Inc.$14.2M1.04%1.88%+267.0%Q4 2023
PRTAProthena Corp Public Ltd Co$13.9M1.02%2.71%-0.8%Q4 2023
LXEOLexeo Therapeutics, Inc.$13.8M1.02%1.91%-9.1%Q2 2024
TSHATaysha Gene Therapies, Inc.$13.7M1.01%0.88%-12.0%Q4 2023
CDTXCidara Therapeutics, Inc.$13.2M0.97%0.19%+177.3%Q4 2024
IVAInventiva S.A.$12.6M0.93%1.40%NewQ4 2025
ESTAEstablishment Labs Holdings Inc.$12.5M0.92%0.59%+89.0%Q3 2024
REPLReplimune Group, Inc.$12.1M0.89%1.56%+26.8%Q2 2025
IONSIonis Pharmaceuticals Inc$11.6M0.85%0.09%+10.0%Q1 2024
RVMDRevolution Medicines, Inc.$11.6M0.85%0.07%+4.3%Q4 2023
AMLXAmylyx Pharmaceuticals, Inc.$10.8M0.79%0.81%+2.8%Q4 2023
CGONCG Oncology, Inc.$10.7M0.79%0.32%+3.7%Q1 2024
TFXTeleflex Inc$9.84M0.72%0.18%NewQ4 2025
IVVDInvivyd, Inc.$9.63M0.71%1.38%-47.1%Q3 2025
REGNRegeneron Pharmaceuticals, Inc.$9.3M0.68%0.01%-23.2%Q1 2024
XENEXenon Pharmaceuticals Inc.$9.14M0.67%0.25%+7.9%Q2 2024
EQEquillium, Inc.$8.69M0.64%9.12%+0.9%Q4 2023
SVRASavara Inc$8.47M0.62%0.69%-29.3%Q1 2024
MAZEMaze Therapeutics, Inc.$7.44M0.55%0.36%+589.3%Q3 2025
TEVATeva Pharmaceutical Industries Ltd$7.36M0.54%0.02%-11.9%Q4 2023
CBIOCrescent Biopharma, Inc.$7.19M0.53%2.20%NewQ4 2025
OVIDOvid Therapeutics Inc.$6.98M0.51%3.29%+33256.7%Q4 2023
BLTEBelite Bio, Inc$6.37M0.47%0.10%NewQ4 2025
VRTXVertex Pharmaceuticals Inc / Ma$6.22M0.46%0.01%+95.9%Q3 2025
BHFBrighthouse Financial, Inc.$6.19M0.45%0.17%+855.2%Q3 2025
AVRAnteris Technologies Global Corp.$6.18M0.45%2.98%+526.9%Q4 2024
AAMApollo Asset Management, Inc.$6.17M0.45%57835.90%Not reportedQ3 2024
TARAProtara Therapeutics, Inc.$6.06M0.45%2.12%+3127.4%Q4 2023
FRNMFreenome, Inc.$5.95M0.44%5.13%-39.1%Q2 2024
DHRDanaher Corp$5.86M0.43%0.00%Not reportedQ4 2024
CLYMClimb Bio, Inc.$5.73M0.42%3.00%+972.8%Q2 2024
Q3 2025Reported Nov 14, 2025193 positions
ABVXAbivax S.A.$115M10.77%2.13%-56.0%Q1 2024
KROSKeros Therapeutics, Inc.$85.3M8.01%13.26%Not reportedQ4 2023
PTGXProtagonist Therapeutics, Inc$65.7M6.17%1.58%+4.3%Q4 2023
ROIVRoivant Sciences Ltd.$50.6M4.76%0.49%+72.5%Q4 2023
SPYSPDR S&P 500 ETF Trust$36.4M3.42%Not reported+141.1%Q2 2025
IMVTImmunovant, Inc.$36.1M3.39%1.28%+319.0%Q4 2023
ETNB89bio, Inc.$31.1M2.92%1.42%+141.2%Q4 2023
ZLABZai Lab Ltd$29.4M2.77%0.08%+2.2%Q4 2023
CYTKCytokinetics Inc$28.5M2.68%0.43%-10.9%Q4 2023
SEPNSepterna, Inc.$22.1M2.08%2.64%+38.9%Q1 2025
PRTAProthena Corp Public Ltd Co$14.3M1.35%2.73%-56.5%Q4 2023
BBIOBridgeBio Pharma, Inc.$14.2M1.33%0.14%+5.3%Q4 2023
ABUSArbutus Biopharma Corp$13.2M1.24%1.51%+2.7%Q4 2023
RAPTRAPT Therapeutics, Inc.$13.1M1.23%3.07%-35.2%Q2 2024
CTMXCytomX Therapeutics, Inc.$12.9M1.21%2.45%+31.3%Q1 2024
AMLXAmylyx Pharmaceuticals, Inc.$11.8M1.11%0.79%-28.1%Q4 2023
BIOABioAge Labs, Inc.$11.1M1.04%5.24%-3.0%Q4 2024
MNPRMonopar Therapeutics$10.6M1.00%1.95%+28.8%Q4 2024
CRNXCrinetics Pharmaceuticals, Inc.$10.3M0.97%0.26%+367.5%Q2 2024
LXEOLexeo Therapeutics, Inc.$10.2M0.96%2.79%+955.7%Q2 2024
CGONCG Oncology, Inc.$10M0.94%0.32%-52.4%Q1 2024
TSHATaysha Gene Therapies, Inc.$9.27M0.87%1.04%-5.8%Q4 2023
REGNRegeneron Pharmaceuticals, Inc.$8.83M0.83%0.02%+367.1%Q1 2024
IONSIonis Pharmaceuticals Inc$8.75M0.82%0.08%-9.9%Q1 2024
JANXJanux Therapeutics, Inc.$8.58M0.81%0.58%+465.4%Q1 2024
IKTInhibikase Therapeutics, Inc.$8.5M0.80%7.01%+2.5%Q4 2024
IVVDInvivyd, Inc.$8.11M0.76%3.44%NewQ3 2025
MTSRMetsera, Inc.$7.98M0.75%0.15%NewQ3 2025
EQEquillium, Inc.$7.95M0.75%9.16%Not reportedQ4 2023
FRNMFreenome, Inc.$7.92M0.74%8.42%Not reportedQ2 2024
QUREuniQure N.V.$7.78M0.73%0.21%Not reportedQ1 2024
PCVXVaxcyte, Inc.$7.67M0.72%0.16%+117.3%Q4 2023
RZLTRezolute, Inc.$7.67M0.72%0.90%-17.5%Q2 2024
XENEXenon Pharmaceuticals Inc.$7.59M0.71%0.25%-27.1%Q2 2024
ASNDAscendis Pharma A/S$7.23M0.68%0.06%+2492.4%Q4 2023
SVRASavara Inc$7.1M0.67%1.15%-44.8%Q1 2024
SRPTSarepta Therapeutics, Inc.$6.74M0.63%0.33%+66.3%Q4 2023
RVMDRevolution Medicines, Inc.$6.5M0.61%0.07%+3.7%Q4 2023
AAMApollo Asset Management, Inc.$6.08M0.57%57835.90%Not reportedQ3 2024
BBOTBridgeBio Oncology Therapeutics, Inc.$5.8M0.55%0.63%+13.2%Q1 2024
VRNAVerona Pharma plc$5.49M0.52%0.01%+80.8%Q3 2024
OACCUOaktree Acquisition Corp. III Life Sciences$5.48M0.51%Not reportedNot reportedQ4 2024
TEVATeva Pharmaceutical Industries Ltd$5.41M0.51%0.02%-22.6%Q4 2023
RYTMRhythm Pharmaceuticals, Inc.$5.01M0.47%0.07%+9.2%Q1 2024
UTHRUNITED THERAPEUTICS Corp$4.7M0.44%0.03%Not reportedQ4 2023
VKTXViking Therapeutics, Inc.$4.62M0.43%0.16%+159.4%Q4 2023
REPLReplimune Group, Inc.$4.1M0.39%1.25%+9312.4%Q2 2025
NKTRNektar Therapeutics$4.1M0.38%0.37%+355.9%Q3 2024
ESTAEstablishment Labs Holdings Inc.$3.72M0.35%0.31%+262.8%Q3 2024
SNYSanofi$3.5M0.33%0.01%+642.1%Q1 2024
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.